XML 20 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating Activities    
Net income available to common shareholders $ 21,619 $ 17,616
Adjustments to reconcile net income to net cash provided by operating activities:    
Accretion and amortization 455 410
(Recovery of) provision for loan losses (849) 181
Depreciation of premises and equipment 1,209 1,270
Deferred income tax expense 1,922 287
Net periodic employee benefit cost 193 111
Unrealized and realized investment securities gains, net (163) (280)
Stock-compensation expense 803 793
Excess tax benefit from stock-compensation expense (77) (155)
Proceeds from life insurance 304 210
Increase in value of bank-owned life insurance (1,016) (612)
Loans originated for sale (4,325) (2,606)
Proceeds from the sale of loans originated for sale 5,939 2,874
Gain on sale of loans (165) (79)
Change in accrued interest receivable (1,233) (305)
Change in other assets (4,193) (11,128)
Change in other liabilities (57) 3,504
Net Cash Provided by Operating Activities 20,366 12,091
Investing Activities    
Net decrease (increase) in loans 26,920 (10,827)
Purchases (61,432) (30,330)
Proceeds from sales 25,062 0
Proceeds from maturities and calls 15,432 13,553
Securities Held-to-maturity: Proceeds from maturities and calls 5,484 2,142
Other Investments: Purchases (9,006) (5,391)
Other Investments: Proceeds from sales 11,715 7,957
Purchases of premises and equipment (1,576) (1,561)
Disposals of premises and equipment 30 55
Net Cash Provided by (Used in) Investing Activities 12,629 (24,402)
Financing Activities    
Net increase in non-interest-bearing deposits 4,514 36,570
Net increase in interest-bearing deposits 63,190 94,758
Net decrease in short-term borrowings (67,228) (56,844)
Purchases of treasury stock (4,089) (13,997)
Proceeds from exercise of stock options 252 280
Dividends paid (8,775) (7,186)
Net Cash (Used in) Provided by Financing Activities (12,136) 53,581
Increase in Cash and Cash Equivalents 20,859 41,270
Cash and cash equivalents at beginning of period 122,991 82,508
Cash and Cash Equivalents at End of Period $ 143,850 $ 123,778